Preservation of spleen and brain function in children with sickle cell anemia treated with hydroxyurea

Abstract

These retrospective data suggest that hydroxyurea at MTD possibly preserves spleen and brain function in children with SCA, and can even result in recovery of splenic function. Higher final Hb concentration during therapy is a significant laboratory predictor of improved splenic function.